sequential AC/Taxol-Trastuzumab regimen
Term · Oncology and biomedicine · MLC-T-ONC-007675
An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-T-T regimen, and AC-TH regimen.
| Identifier | MLC-T-ONC-007675 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | AC-T-T; AC-T-T regimen; AC-TH regimen |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-007675",
"term": "sequential AC/Taxol-Trastuzumab regimen",
"field": "Oncology and biomedicine",
"definition": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-T-T regimen, and AC-TH regimen.",
"synonyms": [
"AC-T-T",
"AC-T-T regimen",
"AC-TH regimen"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/sequential-ac-taxol-trastuzumab-regimen/"
}
Record 14,849 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.